LitCovid-sentences  

PMC:7306567 / 33066-38353 JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function

Id Subject Object Predicate Lexical cue
T246 0-142 Sentence denotes PE Verweij reported grants from Gilead Sciences, MSD, Pfizer and F2G, and non-financial support from OLM and IMMY, outside the submitted work.
T247 143-514 Sentence denotes BJA Rijnders was the investigator for studies supported by Gilead Sciences, Janssen-Cilag, MSD, Pfizer, ViiV; has received research grants from Gilead and MSD; was an invited speaker for Gilead, MSD, Pfizer, Jansen-Cilag, BMS; and an advisory board member for BMS, Abbvie, MSD, Gilead, Jansen-Cilag; he received travel support from BMS, Abbvie, MSD, Gilead, Jansen-Cilag.
T248 515-792 Sentence denotes RJM Brüggemann served as a consultant to Astellas Pharma, Inc., F2G, Amplyx, Gilead Sciences, Merck Sharp & Dohme Corp., and Pfizer, Inc., and has received unrestricted and research grants from Astellas Pharma, Inc., Gilead Sciences, Merck Sharp & Dohme Corp., and Pfizer, Inc.
T249 793-877 Sentence denotes All contracts were through Radboudumc, and all payments were invoiced by Radboudumc.
T250 878-964 Sentence denotes E Azoulay has received fees for lectures from Pfizer, Gilead, MSD, Alexion and Baxter.
T251 965-1051 Sentence denotes His institution received research support from Fisher&Payckle, Jazz pharma and Gilead.
T252 1052-1355 Sentence denotes M Bassetti has received funding for scientific advisory boards, travel and speaker honoraria from Angelini, Astellas, AstraZeneca, Basilea, Bayer, BioMèrieux, Cidara, Correvio, Cubist, Menarini, Molteni, MSD, Nabriva, Paratek, Pfizer, Roche, Shionogi, Tetraphase, Thermo Fisher and The Medicine Company.
T253 1356-1502 Sentence denotes S Blot received research funding from Pfizer and MSD, travel support from Pfizer, MSD and Gilead, and is an invited speaker for Pfizer and Gilead.
T254 1503-1706 Sentence denotes T Calandra reported advisory board membership from Astellas, Basilea, Cidara, MSD, Sobi, ThermoFisher and GE Healthcare and data monitoring board membership from Novartis, all outside the submitted work.
T255 1707-1740 Sentence denotes Fees are paid to its institution.
T256 1741-2086 Sentence denotes CJ Clancy has been awarded investigator-initiated research grants from Astellas, Merck, Melinta and Cidara for projects unrelated to this project, served on advisory boards or consulted for Astellas, Merck, the Medicines Company, Cidara, Scynexis, Shionogi, Qpex and Needham & Company, and spoken at symposia sponsored by Merck and T2Biosystems.
T257 2087-2648 Sentence denotes OA Cornely is supported by the German Federal Ministry of Research and Education and the European Commission, and has received research grants from, is an advisor to, or received lecture honoraria from Actelion, Allecra Therapeutics, Amplyx, Astellas, Basilea, Biosys UK Limited, Cidara, Da Volterra, Entasis, F2G, Gilead, Grupo Biotoscana, Janssen Pharmaceuticals, Matinas, Medicines Company, MedPace, Melinta Therapeutics, Menarini Ricerche, Merck/MSD, Octapharma, Paratek Pharmaceuticals, Pfizer, PSI, Rempex, Scynexis, Seres Therapeutics, Tetraphase, Vical.
T258 2649-2693 Sentence denotes T Chiller reported no conflicts of interest.
T259 2694-2738 Sentence denotes P Depuydt reported no conflicts of interest.
T260 2739-2840 Sentence denotes DR Giacobbe reported honoraria from Stepstone Pharma GmbH and an unconditional grant from MSD Italia.
T261 2841-2887 Sentence denotes NAF Janssen reported no conflicts of interest.
T262 2888-2962 Sentence denotes BJ Kullberg has been a scientific advisor for Amplyx, Cidara and Scynexis.
T263 2963-3130 Sentence denotes K Lagrou received consultancy fees from MSD, SMB Laboratoires Brussels and Gilead, travel support from Pfizer and MSD and speaker fees from Gilead, MSD, FUJIFILM WAKO.
T264 3131-3294 Sentence denotes C Lass-Florl received research funding from Pfizer, Gilead and Egger, travel support from Pfizer, MSD, and Gilead, and is an invited speaker for Pfizer and Gilead.
T265 3295-3401 Sentence denotes RE Lewis has received research support from Merck and has served as an invited speaker for Gilead, Cidara.
T266 3402-3578 Sentence denotes P Wei-Lun Liu has received research grants from MSD, Pfizer, and has served as an invited speaker for Gilead, MSD, Pfizer, Astellas Pharma, and is an advisor to Pfizer, Gilead.
T267 3579-3716 Sentence denotes O Lortholary has served as an invited speaker for Gilead, MSD, Pfizer, Astellas Pharma, and is a consultant for Gilead, Novartis and F2G.
T268 3717-3953 Sentence denotes J Maertens reported personal fees and non-financial support from Basilea Pharmaceuticals, Bio-Rad Laboratories, Cidara, F2G Ltd., Gilead Sciences, Merck, Astellas, Scynexis, and Pfizer Inc. and grants from Gilead Sciences, IMMY and OLM.
T269 3954-4005 Sentence denotes I Martin-Loeches reported no conflicts of interest.
T270 4006-4246 Sentence denotes MH Nguyen has been awarded investigator-initiated research grants from Astellas, Merck, Melinta and Cidara for projects unrelated to this study and served on advisory boards for Astellas, Merck, the Medicines Company, Scynexis and Shionogi.
T271 4247-4443 Sentence denotes TF Patterson reported grants from Cidara to UT Health San Antonio; personal fees from Basilea, Gilead, Mayne, Merck, Pfizer, Scynexis, Sfunga, Toyama and United Medical outside the submitted work.
T272 4444-4617 Sentence denotes TR Rogers has received grants from Gilead Sciences, lecture honoraria from Gilead Sciences and Pfizer Healthcare Ireland, and advisory board membership with Menarini Pharma.
T273 4618-4731 Sentence denotes JA Schouten has received unrestricted educational and research grants from MSD and has been an advisor to Pfizer.
T274 4732-4816 Sentence denotes All contracts were through Radboudumc, and all payments were invoiced by Radboudumc.
T275 4817-4936 Sentence denotes I Spriet has received unrestricted research grants, speaker fees and travel grants from MSD, Pfizer, Gilead and Cidara.
T276 4937-4985 Sentence denotes She has served in the advisory board for Cidara.
T277 4986-5095 Sentence denotes L Vanderbeke is supported by the Flanders Research Foundation (FWO Vlaanderen) through a doctoral fellowship.
T278 5096-5223 Sentence denotes J Wauters reported grants from Gilead Sciences, MSD and Pfizer, and non-financial support from MSD, outside the submitted work.
T279 5224-5287 Sentence denotes FL van de Veerdonk has served as an invited speaker for Gilead.